Serrated colorectal polyps in inflammatory bowel disease

Huaibin M. Ko, Noam Harpaz, Russell B. Mcbride, Miao Cui, Fei Ye, David Zhang, Thomas A. Ullman, Alexandros D. Polydorides

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Serrated colorectal polyps, which, besides hyperplastic polyps, comprise sessile serrated adenomas/polyps and traditional serrated adenomas, are presumptive precursors of at least 20% of sporadic colorectal carcinomas; however, their significance in patients with inflammatory bowel disease is unclear. We retrospectively evaluated 78 serrated polyps, removed over a 14-year period from 6602 inflammatory bowel disease patients undergoing endoscopic surveillance, with respect to morphologic, clinicopathologic, and molecular features, and compared rates of advanced neoplasia (high-grade dysplasia and carcinoma) development following the index serrated polyp diagnosis to reference inflammatory bowel disease cohorts without serrated polyps. Serrated polyps negative for dysplasia, which morphologically resembled sporadic sessile serrated adenoma/polyps, occurred mainly in females, in the proximal colon, and contained BRAF mutations. Serrated polyps with low-grade dysplasia resembled sporadic traditional serrated adenomas and occurred mainly in males, in the distal colon, and contained KRAS mutations. Serrated polyps indefinite for dysplasia were morphologically heterogeneous, but similar to serrated polyps positive for low-grade dysplasia with respect to male predominance, left-sided location, and KRAS mutation rates. Rates of prevalent neoplasia associated with serrated polyps positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 76, 39, and 11%, respectively (P<0.001). Actuarial 10-year rates of incident advanced neoplasia after an initial diagnosis of serrated polyp positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 17, 8, and 0%, respectively, the first and last being significantly different (P=0.02) and comparable to those of corresponding reference populations of inflammatory bowel disease patients with and without low-grade dysplasia at baseline, respectively. We conclude that in serrated polyps from inflammatory bowel disease patients, dysplasia grade correlates with morphology, sex, anatomic location, BRAF and KRAS mutation status, prevalent conventional neoplasia, and rates of advanced neoplasia development.

Original languageEnglish (US)
Pages (from-to)1584-1593
Number of pages10
JournalModern Pathology
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Polyps
Inflammatory Bowel Diseases
Adenoma
Neoplasms
Mutation
Colon
Mutation Rate
Colorectal Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Ko, H. M., Harpaz, N., Mcbride, R. B., Cui, M., Ye, F., Zhang, D., ... Polydorides, A. D. (2015). Serrated colorectal polyps in inflammatory bowel disease. Modern Pathology, 28(12), 1584-1593. https://doi.org/10.1038/modpathol.2015.111

Serrated colorectal polyps in inflammatory bowel disease. / Ko, Huaibin M.; Harpaz, Noam; Mcbride, Russell B.; Cui, Miao; Ye, Fei; Zhang, David; Ullman, Thomas A.; Polydorides, Alexandros D.

In: Modern Pathology, Vol. 28, No. 12, 01.12.2015, p. 1584-1593.

Research output: Contribution to journalArticle

Ko, HM, Harpaz, N, Mcbride, RB, Cui, M, Ye, F, Zhang, D, Ullman, TA & Polydorides, AD 2015, 'Serrated colorectal polyps in inflammatory bowel disease', Modern Pathology, vol. 28, no. 12, pp. 1584-1593. https://doi.org/10.1038/modpathol.2015.111
Ko HM, Harpaz N, Mcbride RB, Cui M, Ye F, Zhang D et al. Serrated colorectal polyps in inflammatory bowel disease. Modern Pathology. 2015 Dec 1;28(12):1584-1593. https://doi.org/10.1038/modpathol.2015.111
Ko, Huaibin M. ; Harpaz, Noam ; Mcbride, Russell B. ; Cui, Miao ; Ye, Fei ; Zhang, David ; Ullman, Thomas A. ; Polydorides, Alexandros D. / Serrated colorectal polyps in inflammatory bowel disease. In: Modern Pathology. 2015 ; Vol. 28, No. 12. pp. 1584-1593.
@article{e66feb07bc7541638cae9502245a7c99,
title = "Serrated colorectal polyps in inflammatory bowel disease",
abstract = "Serrated colorectal polyps, which, besides hyperplastic polyps, comprise sessile serrated adenomas/polyps and traditional serrated adenomas, are presumptive precursors of at least 20{\%} of sporadic colorectal carcinomas; however, their significance in patients with inflammatory bowel disease is unclear. We retrospectively evaluated 78 serrated polyps, removed over a 14-year period from 6602 inflammatory bowel disease patients undergoing endoscopic surveillance, with respect to morphologic, clinicopathologic, and molecular features, and compared rates of advanced neoplasia (high-grade dysplasia and carcinoma) development following the index serrated polyp diagnosis to reference inflammatory bowel disease cohorts without serrated polyps. Serrated polyps negative for dysplasia, which morphologically resembled sporadic sessile serrated adenoma/polyps, occurred mainly in females, in the proximal colon, and contained BRAF mutations. Serrated polyps with low-grade dysplasia resembled sporadic traditional serrated adenomas and occurred mainly in males, in the distal colon, and contained KRAS mutations. Serrated polyps indefinite for dysplasia were morphologically heterogeneous, but similar to serrated polyps positive for low-grade dysplasia with respect to male predominance, left-sided location, and KRAS mutation rates. Rates of prevalent neoplasia associated with serrated polyps positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 76, 39, and 11{\%}, respectively (P<0.001). Actuarial 10-year rates of incident advanced neoplasia after an initial diagnosis of serrated polyp positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 17, 8, and 0{\%}, respectively, the first and last being significantly different (P=0.02) and comparable to those of corresponding reference populations of inflammatory bowel disease patients with and without low-grade dysplasia at baseline, respectively. We conclude that in serrated polyps from inflammatory bowel disease patients, dysplasia grade correlates with morphology, sex, anatomic location, BRAF and KRAS mutation status, prevalent conventional neoplasia, and rates of advanced neoplasia development.",
author = "Ko, {Huaibin M.} and Noam Harpaz and Mcbride, {Russell B.} and Miao Cui and Fei Ye and David Zhang and Ullman, {Thomas A.} and Polydorides, {Alexandros D.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1038/modpathol.2015.111",
language = "English (US)",
volume = "28",
pages = "1584--1593",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Serrated colorectal polyps in inflammatory bowel disease

AU - Ko, Huaibin M.

AU - Harpaz, Noam

AU - Mcbride, Russell B.

AU - Cui, Miao

AU - Ye, Fei

AU - Zhang, David

AU - Ullman, Thomas A.

AU - Polydorides, Alexandros D.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Serrated colorectal polyps, which, besides hyperplastic polyps, comprise sessile serrated adenomas/polyps and traditional serrated adenomas, are presumptive precursors of at least 20% of sporadic colorectal carcinomas; however, their significance in patients with inflammatory bowel disease is unclear. We retrospectively evaluated 78 serrated polyps, removed over a 14-year period from 6602 inflammatory bowel disease patients undergoing endoscopic surveillance, with respect to morphologic, clinicopathologic, and molecular features, and compared rates of advanced neoplasia (high-grade dysplasia and carcinoma) development following the index serrated polyp diagnosis to reference inflammatory bowel disease cohorts without serrated polyps. Serrated polyps negative for dysplasia, which morphologically resembled sporadic sessile serrated adenoma/polyps, occurred mainly in females, in the proximal colon, and contained BRAF mutations. Serrated polyps with low-grade dysplasia resembled sporadic traditional serrated adenomas and occurred mainly in males, in the distal colon, and contained KRAS mutations. Serrated polyps indefinite for dysplasia were morphologically heterogeneous, but similar to serrated polyps positive for low-grade dysplasia with respect to male predominance, left-sided location, and KRAS mutation rates. Rates of prevalent neoplasia associated with serrated polyps positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 76, 39, and 11%, respectively (P<0.001). Actuarial 10-year rates of incident advanced neoplasia after an initial diagnosis of serrated polyp positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 17, 8, and 0%, respectively, the first and last being significantly different (P=0.02) and comparable to those of corresponding reference populations of inflammatory bowel disease patients with and without low-grade dysplasia at baseline, respectively. We conclude that in serrated polyps from inflammatory bowel disease patients, dysplasia grade correlates with morphology, sex, anatomic location, BRAF and KRAS mutation status, prevalent conventional neoplasia, and rates of advanced neoplasia development.

AB - Serrated colorectal polyps, which, besides hyperplastic polyps, comprise sessile serrated adenomas/polyps and traditional serrated adenomas, are presumptive precursors of at least 20% of sporadic colorectal carcinomas; however, their significance in patients with inflammatory bowel disease is unclear. We retrospectively evaluated 78 serrated polyps, removed over a 14-year period from 6602 inflammatory bowel disease patients undergoing endoscopic surveillance, with respect to morphologic, clinicopathologic, and molecular features, and compared rates of advanced neoplasia (high-grade dysplasia and carcinoma) development following the index serrated polyp diagnosis to reference inflammatory bowel disease cohorts without serrated polyps. Serrated polyps negative for dysplasia, which morphologically resembled sporadic sessile serrated adenoma/polyps, occurred mainly in females, in the proximal colon, and contained BRAF mutations. Serrated polyps with low-grade dysplasia resembled sporadic traditional serrated adenomas and occurred mainly in males, in the distal colon, and contained KRAS mutations. Serrated polyps indefinite for dysplasia were morphologically heterogeneous, but similar to serrated polyps positive for low-grade dysplasia with respect to male predominance, left-sided location, and KRAS mutation rates. Rates of prevalent neoplasia associated with serrated polyps positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 76, 39, and 11%, respectively (P<0.001). Actuarial 10-year rates of incident advanced neoplasia after an initial diagnosis of serrated polyp positive for low-grade dysplasia, indefinite for dysplasia, and negative for dysplasia were 17, 8, and 0%, respectively, the first and last being significantly different (P=0.02) and comparable to those of corresponding reference populations of inflammatory bowel disease patients with and without low-grade dysplasia at baseline, respectively. We conclude that in serrated polyps from inflammatory bowel disease patients, dysplasia grade correlates with morphology, sex, anatomic location, BRAF and KRAS mutation status, prevalent conventional neoplasia, and rates of advanced neoplasia development.

UR - http://www.scopus.com/inward/record.url?scp=84949528870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949528870&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2015.111

DO - 10.1038/modpathol.2015.111

M3 - Article

C2 - 26403785

AN - SCOPUS:84949528870

VL - 28

SP - 1584

EP - 1593

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -